VN1R92P

Across TCGA pan-cancer cohorts, VN1R92P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated VN1R92P data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher VN1R92P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VN1R92P expression acts as an unfavorable survival marker, although some lineages such as LAML and BLCA show a favorable association.

LUSC, READ, and MESO are the cancer types where VN1R92P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.100	0.780	<.001	114	view →
READ	OS	Tertile	All	0.198	0.822	<.001	108	view →
MESO	OS	Tertile	III,IV	0.098	0.579	.001	81	view →
ACC	OS	Tertile	All	0.113	0.822	<.001	63	view →
THCA	DFS	Tertile	All	0.077	0.811	<.001	57	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	36	view →
UVM	OS	Tertile	All	0.248	0.769	.007	36	view →
LIHC	OS	Tertile	All	0.144	0.688	.013	27	view →
STAD	OS	Tertile	III,IV	0.176	0.524	.030	18	view →
LAML	DFS	Tertile	All	0.646	0.348	.036	12	view →
BRCA	DFS	Tertile	All	0.819	0.950	.027	9	view →
ESCA	DFS	Tertile	II,III,IV	0.341	0.815	.034	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

VN1R92P–LUSC (OS)

Open the LUSC breakdown →